Detalles de la búsqueda
1.
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Nephrol Dial Transplant
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38858818
2.
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD.
Diabetes Obes Metab
; 26(3): 924-936, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38037539
3.
Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 34(12): 2025-2038, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37872654
4.
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.
J Am Soc Nephrol
; 34(12): 1928-1935, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37807165
5.
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
Kidney Int
; 103(1): 196-206, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367466
6.
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
Diabetes Obes Metab
; 25(6): 1512-1522, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36722675
7.
Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR).
Diabetes Obes Metab
; 25(3): 894-898, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331803
8.
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials.
BMJ Open
; 14(3): e076444, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508632
9.
Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis.
Clin Kidney J
; 16(12): 2461-2471, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046015
10.
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database.
J Nephrol
; 36(1): 45-54, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567698
11.
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
Eur Heart J Cardiovasc Pharmacother
; 9(2): 183-191, 2023 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36639130
12.
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.
Kidney Med
; 5(12): 100730, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046911
13.
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Clin J Am Soc Nephrol
; 2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927680
14.
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD.
Clin Pharmacokinet
; 61(7): 1013-1025, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508594
15.
Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria.
Clin Pharmacokinet
; 61(3): 451-462, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34786651
16.
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Diabetes Care
; 45(4): 888-897, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061867
17.
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.
JAMA Netw Open
; 5(10): e2236123, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36287567
18.
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.
Diabetes Care
; 46(9): 1721, 2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310695
Resultados
1 -
18
de 18
1
Próxima >
>>